Lv1
50 积分 2023-03-23 加入
PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial
14天前
已完结
Efficient and Safe In Vivo Treatment of Primary Hyperoxaluria Type 1 via LNP-CRISPR/Cas9-mediated glycolate oxidase disruption
1个月前
已完结
Heterozygous familial hypercholesterolemia: prevalence and control rates
2个月前
已完结
Lipoprotein apheresis for lipoprotein(a) and cardiovascular disease
3个月前
已完结
Two founder mutations in the LDL receptor gene in Norwegian familial hypercholesterolemia subjects
3个月前
已完结
Lipoprotein(a) and Long-Term Recurrent Infarction After an Acute Myocardial Infarction
3个月前
已完结
Diagnosis and Treatment of Alcohol-Associated Liver Disease
3个月前
已完结
High Risk of Fatty Liver Disease Amplifies the Alanine Transaminase–Lowering Effect of a HSD17B13 Variant
3个月前
已完结
Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)
3个月前
已完结
Chemotherapy-Associated Hepatotoxicities
4个月前
已完结
皖公网安备34019202002308
